Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-N-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | |
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Int. J. of Pharmaceutics, 2016, 510: 30-41; doi.org/10.1016/j.ijpharm.2016.06.026 | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Data in Brief, 2016, 8:1018-1023; doi.org/10.1016/j.dib.2016.06.064 | Link | |
SKMEL-224 |
Human skin malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKMEL-23 |
Human skin malignant metastatic melanoma cell line | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | |||
SKN-BE |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Bertoni et al., J. Biol. Chem., Feb 2011; 286: 4727 - 4741 | Link | |
SKN-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Yang et al., Mol. Neurobiol., 2017, 54:3476-3491 | ||
SKN-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Yang et al., Mol. Neurobiol., 2016, 53:5833-5846; DOI 10.1007/s12035-015-9485-7 | ||
SW-579 |
Human thyroid cancer cell line | ATCC HTB-107 | Human | other | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | Y. Wang et al., Molecular Medicine Reports, 2016, 14: 3509-3516, DOI: 10.3892/mmr.2016.5711 | Link | |
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 | Link | |
SW620 |
Human colon adenocarcinoma cell line | ATCC CCL-227 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. A. Duckworth et al., Oncotarget, 2015, 6(27): 23671-23687 | Link | |
T-24 |
Human urinary bladder cancer cell line | ATCC HTB-4 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | S. Abu-Hamad et al., J. Biol. Chem., May 2008; 283: 13482 - 13490 | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Diaz-Moralli et al., Oncotarget, 2016, 7 (32): 51876-51897 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | RNA-Interference | Metafectene | publication | M.-H. Chien et al., Carcinogenesis, Dec 2009; 30: 2005 - 2013 | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S.-K. Kim et al., Cellular & Molecular Immunology, 2017, 14: 349-359 | Link | |
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. Zheng et al., Nucleic Acids Res., May 2009; 37: 2645 - 2657 | Link | |
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. X. Xu et al., Nan Fang Yi Ke Da Xue Xue Bao, Apr 2006; 26(4): 398-401 | |||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | B. Li et al., ResearchSquare, 2020, doi.org/10.21203/rs.3.rs-58864/v1 | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
U937 |
Human histiocytic lymphoma cell line | ATCC CRL-1593.2 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Innate Immunity, Nov 2014; 20: 799 - 815. | ||
UACC-257 |
Human melanoma cells | Human | skin | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Vamanet al., 2015, PLoS ONE 10(6): e0129219; doi:10.1371/journal.pone.0129219 | Link | ||
WERI-Rb1 |
Human retinoblastoma cell line | ATCC HBT-169 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Liu et al., Pathology - Res. and Practice, 2019, 215, 152641, doi.org/10.1016/j.prp.2019.152641 | Link |